INMUNE BIO INC (INMB:NASDAQ)
$1.89 0.06 (3.2787%)
Analysed INMUNE BIO INC (INMB:NASDAQ) News Sources
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
09-07-2026
yahoo.com
INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
15-07-2026
yahoo.com
INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform
30-07-2026
yahoo.com
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
31-07-2026
yahoo.com
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
06-08-2026
yahoo.com
INmune Bio Inc (INMB) (Q2 2026) Earnings Call Highlights: Regulatory Wins and Strategic Focus ...
07-08-2026
yahoo.com
INmune Bio (INMB) Q2 2026 Earnings Call Transcript
07-08-2026
fool.com
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
26-08-2026
yahoo.com
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
14-09-2026
yahoo.com
INmune Bio to Attend the 2026 Maxim Growth Summit
06-10-2026
yahoo.com
What is the current price of INMUNE BIO INC (INMB:NASDAQ)?
The current price of INMUNE BIO INC (INMB:NASDAQ) is $1.89.
INMUNE BIO INC (INMB:NASDAQ) absolute price change since previous trading day?
The absolute price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is $0.06.
INMUNE BIO INC (INMB:NASDAQ) percentage price change since previous trading day?
The percentage price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is 3.2787%.
What is the most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ)?
The most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for INMUNE BIO INC (INMB:NASDAQ)?
The most recent sentiment for INMUNE BIO INC (INMB:NASDAQ) is .
SEC-8K** Filing Available For INMUNE BIO INC (INMB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.